Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Timothy J Pluard"'
Autor:
Linda M. Liau, Keyoumars Ashkan, David D. Tran, Jian L. Campian, John E. Trusheim, Charles S. Cobbs, Jason A. Heth, Michael Salacz, Sarah Taylor, Stacy D. D’Andre, Fabio M. Iwamoto, Edward J. Dropcho, Yaron A. Moshel, Kevin A. Walter, Clement P. Pillainayagam, Robert Aiken, Rekha Chaudhary, Samuel A. Goldlust, Daniela A. Bota, Paul Duic, Jai Grewal, Heinrich Elinzano, Steven A. Toms, Kevin O. Lillehei, Tom Mikkelsen, Tobias Walbert, Steven R. Abram, Andrew J. Brenner, Steven Brem, Matthew G. Ewend, Simon Khagi, Jana Portnow, Lyndon J. Kim, William G. Loudon, Reid C. Thompson, David E. Avigan, Karen L. Fink, Francois J. Geoffroy, Scott Lindhorst, Jose Lutzky, Andrew E. Sloan, Gabriele Schackert, Dietmar Krex, Hans-Jorg Meisel, Julian Wu, Raphael P. Davis, Christopher Duma, Arnold B. Etame, David Mathieu, Santosh Kesari, David Piccioni, Manfred Westphal, David S. Baskin, Pamela Z. New, Michel Lacroix, Sven-Axel May, Timothy J. Pluard, Victor Tse, Richard M. Green, John L. Villano, Michael Pearlman, Kevin Petrecca, Michael Schulder, Lynne P. Taylor, Anthony E. Maida, Robert M. Prins, Timothy F. Cloughesy, Paul Mulholland, Marnix L. Bosch
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-9 (2018)
Abstract Background Standard therapy for glioblastoma includes surgery, radiotherapy, and temozolomide. This Phase 3 trial evaluates the addition of an autologous tumor lysate-pulsed dendritic cell vaccine (DCVax®-L) to standard therapy for newly di
Externí odkaz:
https://doaj.org/article/7b4a8b2c7d344b0e9344d197a7338b0a
Publikováno v:
Cancer Research. 82:P5-15
Previous research has demonstrated that patients express a desire to discuss advance care planning (ACP). ACP has been associated with numerous positive outcomes including improved patient satisfaction, improved quality of life in terminal illness, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4235681c5481d136f30f6c14f17f58e
https://doi.org/10.1158/1538-7445.sabcs21-p5-15-03
https://doi.org/10.1158/1538-7445.sabcs21-p5-15-03
Autor:
Stephen Johnston, Timothy J Pluard, Judy S Wang, Erika P Hamilton, Dejan Juric, Catherine R Scholz, Elizabeth Hnitecki, Sara Dar, Lei Gao, Lisa Cantagallo, Manav Korpal, Jianjun Alan Xiao, Lihua Yu, Tarek Sahmoud, Antonio Gualberto
Publikováno v:
Cancer Research. 82:P1-17
Background: H3B-6545, a novel Selective ERα Covalent Antagonist (SERCA), inactivates both mutant and wild-type ERα by targeting cysteine 530 and enforcing antagonist conformation. It demonstrated a manageable safety profile and single-agent antitum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a929ce0d9e99e2c19e565df11cf79fd9
https://doi.org/10.1158/1538-7445.sabcs21-p1-17-03
https://doi.org/10.1158/1538-7445.sabcs21-p1-17-03
Autor:
Ashiq Masood, Janakiraman Subramanian, Arif Hussain, Timothy J. Pluard, Kevin F. Kennedy, Megan E. McNally, Lee S. Cummings, Urooge Boda, Waled Bahaj, Zaheer Ahmed, Omer M. Toor
Supplementary Table 1. Common genes between Caris, Paradigm and Guardant360 platforms Supplementary Table 2: Common mutations between Guardant 360 and Caris/Paradigm platforms Supplementary Table 3: Actionable mutations detected both in tissue and bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfdb1078c62ec52b361cb7ff2cdd7e20
https://doi.org/10.1158/1535-7163.22505515.v1
https://doi.org/10.1158/1535-7163.22505515.v1
Autor:
Ashiq Masood, Janakiraman Subramanian, Arif Hussain, Timothy J. Pluard, Kevin F. Kennedy, Megan E. McNally, Lee S. Cummings, Urooge Boda, Waled Bahaj, Zaheer Ahmed, Omer M. Toor
Next-generation Sequencing (NGS) of cancer tissues is increasingly being carried out to identify somatic genomic alterations that may guide physicians to make therapeutic decisions. However, a single tissue biopsy may not reflect complete genomic arc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b62820b97ce5ea3a45118a232749250c
https://doi.org/10.1158/1535-7163.c.6538099.v1
https://doi.org/10.1158/1535-7163.c.6538099.v1
Autor:
Emily Brugioni, Elizabeth Cathcart-Rake, Janie Metsker, Elizabeth Gustafson, Lindsey Douglass, Timothy J. Pluard
Publikováno v:
Clinical Breast Cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f80b81addb7ee686d4452ea3098a7f24
https://doi.org/10.1016/j.clbc.2023.04.006
https://doi.org/10.1016/j.clbc.2023.04.006
Autor:
Cynthia X. Ma, Jingqin Luo, Rachel A. Freedman, Timothy J. Pluard, Julie R. Nangia, Janice Lu, Frances Valdez-Albini, Melody Cobleigh, Jason M. Jones, Nancy U. Lin, Eric P. Winer, P. Kelly Marcom, Shana Thomas, Jill Anderson, Brittney Haas, Leslie Bucheit, Richard Bryce, Alshad S. Lalani, Lisa A. Carey, Matthew P. Goetz, Feng Gao, Gretchen Kimmick, Mark D. Pegram, Matthew J. Ellis, Ron Bose
Publikováno v:
Clinical Cancer Research. 28:1258-1267
Purpose:HER2 mutations (HER2mut) induce endocrine resistance in estrogen receptor–positive (ER+) breast cancer.Patients and Methods:In this single-arm multi-cohort phase II trial, we evaluated the efficacy of neratinib plus fulvestrant in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d357d0a2b1a205913601e78774f534c
https://doi.org/10.1158/1078-0432.ccr-21-3418
https://doi.org/10.1158/1078-0432.ccr-21-3418
Autor:
Joyce O'Shaughnessy, Janet Horton, Jessica Sorrentino, Jie Xiao, Dušan Milenković, Sharon T. Wilks, Donald A. Richards, Ling Ma, Nikola Vasev, Željko Vojnović, Hyo S. Han, Timothy J. Pluard, Lazar Popovic, Michael A. Danso, Anu R. Thummala, Gail S. Wright, Antoinette R. Tan
Supplementary Data from Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49367a56074e10ea478cbc6f19140f8e
https://doi.org/10.1158/1078-0432.22483883
https://doi.org/10.1158/1078-0432.22483883
Autor:
Matthew J.C. Ellis, Hussam Al-Kateb, Philippe L. Bedard, Kimberly Blackwell, Mark Pegram, Daniel F. Hayes, John Pfeifer, Alshad S. Lalani, Richard Bryce, Richard B. Lanman, Kimberly C. Banks, Caroline Bumb, Jill Anderson, Shana Thomas, Polly Ann Niravath, Carey Anders, Timothy J. Pluard, Andres Forero, Melody Cobleigh, Debu Tripathy, Christy Russell, Matthew P. Goetz, Michael Naughton, Eric Winer, Gretchen Kimmick, Melinda L. Telli, Rachel A. Freedman, Feng Gao, Ron Bose, Cynthia X. Ma
Supplementary Figures S1, S2, S3 and Tables S1, S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5384652f0eadf512c7d1da5595ef47ed
https://doi.org/10.1158/1078-0432.22467027.v1
https://doi.org/10.1158/1078-0432.22467027.v1
Autor:
Ron Bose, Matthew J. Ellis, Mark D. Pegram, Gretchen Kimmick, Feng Gao, Matthew P. Goetz, Lisa A. Carey, Alshad S. Lalani, Richard Bryce, Leslie Bucheit, Brittney Haas, Jill Anderson, Shana Thomas, P. Kelly Marcom, Eric P. Winer, Nancy U. Lin, Jason M. Jones, Melody Cobleigh, Frances Valdez-Albini, Janice Lu, Julie R. Nangia, Timothy J. Pluard, Rachel A. Freedman, Jingqin Luo, Cynthia X. Ma
Supplementary Figure from The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90c831991bea182c20f9da15faab26d1
https://doi.org/10.1158/1078-0432.22487735.v1
https://doi.org/10.1158/1078-0432.22487735.v1